26027-37-2

Basic information

• Product Name: POE OLEIC AMIDE
• Synonyms: (z)-ydroxy;2-ethanediyl),.alpha.-[2-[(1-oxo-9-octadecenyl)amino]ethyl]-.omega.-hydroxy-,(Z)-Poly(oxy-1;Ethoxylatedoleicmonoethanolamide;Ethoxylatedoleoamide;poly(oxy-1,2-ethanediyl),alpha-[2-[(1-oxo-9-octadecenyl)amino]ethyl]-omega-h;Poly(oxy-1,2-ethanediyl), .alpha.-(9Z)-2-(1-oxo-9-octadecenyl)aminoethyl-.omega.-hydroxy-;Poly(oxy-1,2-ethanediyl), alpha-[2-[(1-oxo-9-octadecenyl)amino]ethyl]-omega-hydroxy-, (Z)-;Polyethyleneglycol oleylamide
• CAS NO: 26027-37-2
• Molecular Formula: (C2H4 O)n C20 H39 N O2
• Mol File: 26027-37-2.mol
• Article Data: 2

Chemical Properties

• Appearance: /
• CAS DataBase Reference: POE OLEIC AMIDE(CAS DataBase Reference)
• NIST Chemistry Reference: POE OLEIC AMIDE(26027-37-2)
• EPA Substance Registry System: POE OLEIC AMIDE(26027-37-2)

Safety Data

• Hazardous Substances Data: 26027-37-2(Hazardous Substances Data)

Upstream product

• 1046804-96-9 N-(2-(2-(2-(2-(2-(2-trityloxy)ethoxy)ethoxy)ethoxy)ethoxy)ethoxy)ethyloleoylamide 
• 112-80-1 cis-Octadecenoic acid 
• 929-06-6 2-(2-Aminoethoxy)ethanol 

Relevant articles and documents

THE TETRACYCLIC ANTHRAQUINONES POSSESSING ANTI-CANCER EFFECT

The present invention provides aminoside tetracyclic anthraquinones represented by formula (I) or formula (II), wherein the piptides are introduced to connect tetracyclic anthraquinones and fatty acid saturated or unsaturated in order to make the anticancer agents to be absorbed and released selectively; meanwhile some water-solubility groups are also introduced into the branched chain, aminosaccharide and tetracyclic moiety of the compounds to improve the water-solubility. The present invention also provides the preparative method and the use thereof as pharmaceutically active components for treating the diseases cured by aminoside tetracyclic anthraquinone, for example cancer, such as intestines, liver, gastric, breast, lung, ovary, prostate, brain glioma, lymph, skin, pigment, thyroid gland, multiple bone marrow cancer and leukemia.